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Pancreatic acinar membranes SOMATOSTATIN-14 (SSJ is a tetradecapeptide synthesized in endocrine D cells that is widely distributed in the gastrointestinal tract (4, 21) and is known to inhibit the stimulatory effects of various secretagogues on a number of cell functions, including endocrine and exocrine functions of the pancreas (53) . More recently, SS analogues have been shown to inhibit the growth of normal and tumoral cells (:23,45 ). In the pancreas, SS inhibited normal (23,45) and caerulein-stimulated pancreatic growth (31, 42) , whereas the neutralization of the endogenous SS with antiserum amplified the growth-stimulating effect of caerulein (31). These observations have led to the suggestion that this peptide has a physiologically important function in the regulation of normal cell growth and that it might be a negative regulator of pancreatic acinar cell proliferation in vivo. SS exerts its physiological actions by interacting with membrane-bound receptors (48, 58) , which are coupled to adenylate cyclase (43), K' channels (61) , voltage-dependent Ca*' channels (62) , and tyrosine phosphatase (12). In addition, several authors have shown that SS increases the guanylate cyclase activity in several tissues (11, 17, 54) . Recent studies argue that, in contrast to cyclic AMP (57) , cyclic GMP has a role in the antiproliferative effect of ss (41).
One strong stimulant of exocrine pancreatic growth in the rat is a total gastrectomy, which results in acinar cell hyperplasia 2 weeks after the intervention (10). To determine whether SS is involved in exocrine pancreas growth responses in vivo, we measured the status of SS binding and pancreatic somatostatin-like immunoreactivity (SS-LI) content in control pancreas and during pancreatic proliferation 2 weeks after gastrectomy in rats. This study also examines the basal activity of the guanylate cyclase ' Requests for reprints shou'ld be addressed to E. Aritla.
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system as well as the stimulatory effect of SS on this enzyme activity in these membranes. Cholecystokinin (CCK) is the major humoral candidate in promoting postgastrectomy pancreatic hyperplasia (9, 29) . Proglumide, an antagonist of the receptors of the gastrin/CCK peptide family (37). was used to evaluate whether the effects of gastrectomy on the pancreatic somatostatinergic system involved the activation of gastrin/CCK receptors. Protein tyrosine phosphatases have been reported to play a crucial role in cellular processes involving protein phosphorylation such as growth and differentiation (60) . The fact that tyrosine phosphatase activity is stimulated by growth factor inhibitors, like SS (50) and transforming growth factor p (TGF-P) (20), and by differentiating agents (5 153) that inhibit cell growth suggests an inverse relationship between tyrosine phosphatase activity and cell growth. Therefore, protein tyrosine phosphatase activity was also determined in the membrane preparations previously cited.
Preparation of Rat Pancreatic Acinar Membranes
as a standard.
Dispersed pancreatic acini were obtained from male Wistar rats after enzymatic degradation of the pancreas with 0.2 units of collagenase/ml in an oxygenated Krebs-Ringer medium as described by Amsterdam et al. (2) . After washing by sedimentation, acini were transferred to 0.3 M sucrose, 0.03% soybean trypsin inhibitor, 0.1 mM PMSF, and 1 mM benzamidine (buffer A). In this buffer, the acini were homogenized at 4°C by use of a Potter homogenizer. After centrifugation at 600 X g for 5 min at 4"C, the supematant was resuspended in buffer A and centrifuged at 100,000 x g in a TLA 100.3 rotor for 1 h. The supematant was discarded and the pellet was resuspended in 50 mM Tris-HCl, pH 7, 0.5 mg/ml bacitracin, 0.2 m&f CaCl*, 0.03% soybean trypsin inhibitor, 0.1 mM PMSF, 1 mM benzamidine, and 5% glycerol (buffer B). An aliquot was taken for protein determination by the method of Lowry et al. (27) with bovine serum albumin
METHOD
Materials
Binding of [y-'*P]ATP was from NEN (Les Ulis, France). Sephacryl S-300 HR was from Pharmacia (Uppsala, Sweden). Carrier-free Na['2'I] (IMS 300, 100 mCi/ml), the rabbit antibody used in the radioimmunoassay technique, and the cGMP kit were purchased from the Radiochemical Center (Amersham, UK). This antiserum was raised in rabbits against SS conjugated to BSA and is specific for SS, but because SS constitutes the C-terminal portion of both somatostatin-(SS-25) and somatostatin-28 (SS-28), the antiserum does not distinguish between these three forms. The binding of SS to this antibody does not depend on an intact disulfide bond in the molecule, because breaking the disulfide bond by reaction with 0.1% mercaptoethanol(5 min boiling water bath) does not change peptide immunoreactivity.
Cross-reactivity with other peptides was less than 0.5%. Cross-reaction with several SS analogues demonstrated that neither the N-terminal glycine nor the C-terminal cysteine residues are required for antibody binding, suggesting that the antigen site is directed towards the central part of the molecule containing the tryptophan residue. All other reagents were of the highest purity commercially available.
Experimental Animals
Male Wistar rats with an initial body weight of 200-250 g were used for the study. Animals were fasted for 12 h before surgery. Using ether anesthesia, total gastrectomy was performed through a midline incision by removing the entire stomach. The vagal trunks were preserved and continuity restored by end-toend anastomosis between the esophagus and duodenum. Sham operation was performed by making and repairing an incision in the stomach. In the proglumide-treated groups, the animals received two times daily for 2 weeks an IP injection of proglumide (20 mg/kg). Proglumide was dissolved in saline solution. Postoperatively the rats were maintained on a 5% glucose diet for the first 24 h, then allowed free access to standard chow and tap water. These rats were sacrificed by decapitation 2 weeks after the intervention and the pancreas was removed and trimmed free of fat, connective tissues, and lymph nodes.
Binding of ['251-Tyr"]SS was assayed on pancreatic acinar membranes from Wistar rats by a modified method (12). ['251-Tyr' ']SS was radioiodinated by chloramine-T iodination according to the method of Greenwood (19). Separation of iodinated SS from unincorporated iodine was carried out on a Sephadex G-25 (fine) column equilibrated and eluted with 0.1 M acetic acid in BSA (0.1% w/v). The specific activity of the radioligand was 600 Ci/mmol.
Binding of [?-Tyr' ']SS to pancreatic acinar membranes was carried out in a total volume of 250 ~1 in 50 mM Tris-HCl buffer (pH 7.4) containing 0.5 mM MgC&, 3 mM NaCl, 0.2 mM CaC12, 0.2% (w/v) BSA, 0.5 mg/ml bacitracin, and 0.3 mg/ml soybean trypsin inhibitor (binding buffer). Plasma membranes (140 pg of protein/ml) were incubated for 90 min at 20°C with 100 pM [12'1-Tyr"]SS in the absence or presence of unlabeled SS. Bound and free ligand was separated by centrifugation at 11,000 X g for 4 min at 4°C in a microcentrifuge.
Radioactivity in the pellet was measured with a gamma scintillation counter. Nonspecific binding was estimated as membrane-associated radioactivity in the presence of 1 ,uM SS and specific binding was calculated as the difference between total and nonspecific membrane-associated radioactivity.
Evaluation of Radiolabeled Peptide Degradation
To determine the extent of tracer degradation during incubation, we measured the ability of preincubated peptide to bind to fresh pancreatic acinar membranes. Briefly, ['251-Tyr"]SS (100 PM) was incubated with pancreatic acinar membranes (140 pg protein/ml) for 90 min at 20°C. After this preincubation, aliquots of the medium were added to fresh pancreatic acinar membranes and incubated for an additional 90 min at 20°C. The fraction of the added radiolabeled peptide that specifically bound during the second incubation was measured and expressed as a percentage of the binding that was obtained in control experiments performed in the absence of pancreatic acinar membranes during the preincubation period. Pancreatic acinar cell membranes from all the groups showed a similar peptide degradation capacity and the values varied by no more than 9% in all the experimental groups.
Measurement of the Particulate Guanylate Cyclase Activity
The activity of particulate guanylate cyclase in pancreatic acinar membranes was measured using the method previously described (16,25) with a slight modification. The membranes (50 pg protein/l0 ~1) were resuspended in 50 mh4 Tris-HCl, pH 7.6, and used for the assay of guanylate cyclase activity. A lo-p1 aliquot of the particulate fraction was added to tubes containing 80 ~1 of a reaction mixture containing (final concentrations) 50 mM Tris-HCl, pH 7.6,40 mM MnCl,, 1 mM GTP, 1 mM IBMX, 0.01% bacitracin, and a GTP-regenerating system that consisted of 15 mM creatine phosphate and 20 /lg of creatine phosphokinase. After incubation at 3'7°C for 10 min with or without SS ( 10m7-lo-" M) the reaction was stopped by the addition of 900 ~1 of 50 mM sodium acetate, pH 4.0, followed by heating at 90°C for 3 min. The heated incubation mixture was centrifuged at 2000 X g for 20 min and the supematant fraction was evaporated to dryness. The amount of cyclic GMP generated was determined in the dry extract by radioimmunoassay.
Tissue Extraction and SS R(!zdioimmunoassay
For SS-LI measurement, the pancreata were rapidly homogenized in 1 ml 2 M acetic acid using a Brinkman polytron (setting 5, 30 s). The extracts were boiled for 5 min in an ice-chilled water bath, and aliquots (100 ~1) were removed for protein determination (27) . The homogenates were subsequently centrifuged at 15,000 x g for 15 min at 4°C and the supematant was neutralized with 2 M NaOH. The extracts were stored at -70°C until assay. The SS concentration was determined in tissue extracts by a modified radioimmunoassay method (36) , with a sensitivity limit of 10 pglml. Incubation tubes prepared in duplicate contained 100-/J samples of tissue extracts or standard solutions of O-500 pg cyclic SS diluted in phosphate buffer (0.05 M, pH 7.2, containing 0.3% BSA, 0.01 M EDTA), 200 ~1 appropriately diluted anti-SS-serum, 100 ~1 freshly prepared ['251-Tyr"]SS diluted in buffer to give 6003 cpm (equivalent to 5-10 pg), in a final volume of 0.8 ml. All reagents as well as the assay tubes were kept chilled on ice before incubation for 48 h at 4°C. Bound hormone was separated from free hormone by the addition of 1 ml dextran-coated charcoal (dextran T-70,0.2% w/v, Pharmacia; charcoal: Norit A, 2% w/v. Serva, Feinbiochemica, Heidelberg, Germany). Serial dilution curves for the samples were parallel with the standard curve. The intra-and interassay variation coefficients were 6.0% and 8.8%, respectively.
Preparation of A431 Membranes
A431 cells were washed once with 10 m&l sodium phosphate, pH 7, and 150 mMNaC1 (NaCl/PJ and scraped into 10 mMNaCl/ P,, pH 7 (18). The cells were collected by centrifugation, suspended in 50 mM Tris-HCI, pH 7, containing 0.03% soybean trypsin inhibitor, 0.5 mg/ml bacitracin, and lysed by freezethawing in liquid nitrogen. The lysate was centrifuged at 170 X g for 5 min. The subsequent supematant was centrifuged at 25,000 x g for 30 min. The final pellet was resuspended in the 50 mM Tris-HCl, pH 7, containing 0.03% soybean trypsin inhibitor and 0.5 mg/ml bacitracin (12).
Preparation of Phosphorylated Poly(Glu, Tyr)
Phosphorylated poly(Glu,Tyr) was prepared by incubating 7.2 mg polymer with 1.5-2 rg A431 cell membranes in 50 mM Tris-HCl, containing 0.1 pM epidermal growth factor, 250 PM [Y-~~P]ATP (700 dpm/pmol), 100 fl orthovanadate, 5 mM MnCl*, and 0.1% Nonidet .P-40 at pH 7.5 (12). The reaction was allowed to proceed for 16 h at 4"C, then the mixture was subjected to gel filtration on a !jephacryl S300 HR column. Fractions containing the phosphorylated poly(Glu,Tyr) were pooled and concentrated in a Centricon-Amicon microconcentrator; IOO-~1 aliquots were stored at -20°C.
Assay for Phosphotyrosine Phosphatase Activity
PTPase activity was measured by the release of ["PIorthophosphate from '2P-labeled poly(Glu,Tyr) in a 100-p reaction mixture containing 30,000 cpm "2P-labeled poly(Glu,Tyr) (final concentration of 0.3 PM) and 3 pg acinar pancreatic membrane proteins in buffer B containing 0.1% albumin. The reaction was allowed to proceed for 5 min at 3O"C, then stopped by the addition of 100 ~130% trichloroacetic acid. The mixtures were kept on ice for 30 min, then centrifuged at 10,000 X g for 10 min to remove the denatured proteins. The inorganic ["'PIphosphate liberated was extracted using the molybdate extraction procedure (3) and radioactivity was evaluated by liquid scintillation. The amount of "P, released was determined from the specific radioactivity of [y-'*P]ATP used for the phosphorylation reaction. One unit PTPase activity was defined as the amount that released 1 nmol phosphate/min at 30°C from radiolabeled substrate.
Data Analysis
The computer program LIGAND (34) was used to analyze the binding data. The use of this program made it possible to select the receptor models that best fit a given set of binding data. The same program was also used to present data in the form of Scatchard plots (44) and to compute the values for receptor affinity (&) and density (B,,,) that best fit the sets of binding data for each rat. Statistical comparisons of all the data were analyzed by ANOVA and the Newman-Keuls r-test. Means among groups were considered significantly different when the value was p < 0.05. Each individual experiment was performed in duplicate.
RESULTS
Two weeks following total gastrectomy, the weight of the pancreas increased significantly by 30% (p < 0.001) when compared to sham-operated rats. Pancreatic acinar membrane PTPase activity decreased (74% of control) 2 weeks after total gastrectomy, coinciding with hyperplasia of exocrine pancreatic tissue previously described (Fig. 1) . Figure 2 shows that pancreatic SS-LI content 2 weeks after total gastrectomy was significantly lower (55% of control levels) than in control rats.
The specific binding of SS to rat pancreatic acinar membranes increased (146% of control) after gastrectomy compared to con- (Fig. 3) , the binding data were significantly higher in the gastrectomized group throughout the whole range studied. Scatchard plots of the stoichiometric binding data were linear and essentially parallel (Fig. 3, right panel) . Interpretation of these data with the LIGAND computer program (34) resulted in the best fit for a model with one type of SS receptor. Pancreatic acinar membranes from gastrectomized rats exhibited significant increases in the maximum SS binding capacity. However, the corresponding K,, values remained unchanged after gastrectomy.
The modulation of guanylate cyclase by SS was studied in pancreatic acinar membranes from control and gastrectomized rats. No significant differences were seen for basal guanylate cyclase activities between the control group and the gastrectomized group. The capacity of SS to stimulate guanylate cyclase activity in control and gastrectomized rats is shown in Table 2 . SS increased by twofold guanylate cyclase activity in pancreatic membranes from gastrectomized rats.
Because the major humoral candidate for promoting pancreatic hyperplasia after gastrectomy appears to be CCK (9,29), a group of gastrectomized rats was treated with proglumide, an antagonist of receptors of the gastrin/CCK peptide family to evaluate whether the effects of gastrectomy on the pancreatic somatostatinergic system involved the activation of gastrin/CCK. Proglumide suppressed the inhibitory effect of gastrectomy on basal tyrosine phosphatase activity and SS-LI content which returned to control levels ( Figs. 1 and 2) . Furthermore, proglumide suppressed the increase of the number of SS receptors and that of guanylate cyclase activity induced by gastrectomy (Fig.3 , Tables  1 and 2 ). Proglumide was also administered to sham-operated control rats without producing significant differences with the controls in any of the studied parameters.
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pancreatic acinar membranes because the gastrectomy-induced changes in the somatostatinergic system were prevented by the gastrin/CCK receptor antagonist proglumide. In addition, proglumide alone had no demonstrable effect on these parameters. Two types of receptors for the gastrin/CCK peptide family have been identified in pancreatic acinar cells (37, 59) : the CCK, receptors, which have a much higher affinity for CCK than for gastrin (37); and the gastrin receptors (CCKs or CR), which have approximately the same affinity for CCK and gastrin (37).
The increase in the number of SS receptors observed during pancreatic acinar cell hyperplasia 2 weeks after total gastrectomy is consistent with the view that SS may function as a negative regulator of pancreatic acinar cell proliferation in vivo (31, 42, 46) . Pancreatic acinar cells, which do not synthesize SS but possess functional receptors for SS (48, 58) , may respond to SS produced in the pancreas by the D cells in the islets of Langerhans as well as to circulating SS.
Recently we found that exocrine pancreatic growth observed after proximal small bowel resection is accompanied by an increase in the number of SS receptors at 2 weeks and 1 month after intestinal surgery (1). In addition, in pancreatic tumor cells AR42J, we also observed an increase in the number of SS receptors after treatment of cells with gastrin and epidermal growth factor (EGF) (and with CCK, not published), which stimulate cell growth (55) . In contrast, conditions that decrease cell growth, such as treatment with glucocorticoids, decrease the number of SS receptors on AR42J cells (56) . All these results suggest that pancreatic acinar cell growth is associated with upregulation of SS receptors and this could represent a mechanism promoted by the cell to negatively regulate the mitogenic activity of pancreatic growth factors such as CCK.
Although at least five SS receptor subtypes have been cloned (6), only SSTR3 (63) and SSTRS (38) are present in the islets of Langerhans whereas the exocrine pancreas appears to express only receptor subtype 2 (SSTR2) (8). Vidal et al. (55) also reported that AR42J cells expressed SSTR2 subtype strongly and that the gash-in-and EGF-induced increase in SS receptors was due to upregulation in SSTR2 subtype receptors. All these results suggest that the increase in SS receptor number after gastrectomy
DISCUSSION
Gastrectomy increased pancreatic growth (10) and this effect was associated with an increase in the number of SS receptors without alteration of affinity.
The molecular basis for the increased number of SS receptors after gastrectomy is uncertain. Because growth factor-induced cell division is paralleled by heteroregulation of other cell surface receptors (7), it is possible that SS receptors are targets for heterologous regulation by growth factors. Thus, the increase of SS receptors could be secondary to the CCK mitogenic signal (13, 32) . In this regard, the CCK receptors seem to mediate the action of gastrectomy on the SS receptor-effector system in the Table 1 . With respect to postreceptor mechanisms, recently Viguerie et al. (57) and Alvaro-Alonso et al. (1) reported that the cyclic AMP pathway is not involved in the inhibitory effect of SS of pancreatic cell growth. Because recent papers support a role for cyclic GMP in the antiproliferative effect of SS (41), the present study has examined the effect of SS on guanylate cyclase activity in pancreatic acinar cell me:mbranes from control and gastrectomized rats. The cyclic GMP levels in pancreatic acinar membranes obtained in the present shady are similar to those obtained by in mesangial cells and by Catalan et al. (11) in the cerebral cortex, and lower than those obtained by Vesely et al. (54) in the pancreas. However, the two latter authors measured the guanylate cyclase activity in the supematant, whereas our study and that of measured the guanylate cyclase activity in the pellet. The present results show that SS increases guanylate cyclase activity significantly in the operated rats. However, the increase is not significant in the control rats, where it is comparable to the effect of proglumide alone. The increase does not appear to be due to a change in the number of molecules of guanylate cyclase itself because the activity levels were similar in membranes from both In addition to the intestinal mucosa, which preferentially releases SS-28 (.5), a major site of endogenous SS release is located within the pancreas itself, namely in the D cells of the islets of Langerhans. The close interaction between the islets and the exocrine tissue appears to be at least partially mediated by an insuloacinar portal system (26,35). Thus, because of the relatively short plasmatic half-life of SS, which has been estimated to be approximately l-2 min for SS and approximately 4 min for SS-28 (52), it seems that islet-released SS might act via the insuloacinar portal system (33). Hence, despite low peripheral plasma levels, relatively high local plasma concentrations would be present around the acinar tissue and this probably has functional relevance (33). Therefore, the present study measured pancreatic SS-LI content. The pancreatic SS-LI levels in the control rats were similar to those previously reported by others (36) . Gastrectomy decreased pancreatic SS-LI content compared with controls. These results also agree with other experimental models of pancreatic growth studied by our group. Thus, two weeks after enterectomy, the situation is similar: increased SS receptors and decreased SS-LI (albeit not significant after enterectomy). Total gastrectomy leads to increased CCK (29) and glucagon (14) plasma levels compared to controls. Because it has been demonstrated that CCK and glucagon increases SS secretion (30), the decrease of pancreatic SS-LI levels in response to gastrectomy could be a consequence of increased plasma levels of both hormones.
Cell membrane-associated tyrosine phosphatase activities have been characterized in various tissues (15, 24) . Recently, Colis et al. (12) demonstrated that the level of tyrosine phosphatase activity in rat pancreatic acinar cells is as high as that observed in some rich sources of tyrosine phosphatase such as rat spleen (49) or rabbit kidney (47). The control values of the present study are in agreement with previously reported values. Gasttectomy decreased tyrosine phosphatase activity. The regulation of protein phosphorylation level in tyrosine residues is well known to be involved in cellular activities associated with growth and dif- 
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ferentiation. Indeed, it has been demonstrated that CCK stimulated tyrosine kinase activity in pancreatic acini (28) and this stimulation is associated with the growth-promoting effect of caerulein (40). Conversely, SS stimulation of membrane tyrosine phosphatase activity has been shown to be involved in the antiproliferative effect of SS in pancreatic tumor cells (50). The decrease of tyrosine phosphatase activity observed after gastrectomy is like that observed after pancreatectomy during the regeneration process associated with pancreatic growth (40). These observations suggest that the negative regulation of tyro-
